Ethnic Differences and the Ischemia/Bleeding Risk of DAPT Duration

Seoul National University

Status: Unknown

Conditions: Coronary Artery Disease; Percutaneous Coronary Intervention; Dual Antiplatelet Therapy

Treatments: Drug: prolonged DAPT

Study type: Observational

Funder types: Other

Identifiers

NCT03338335

DAPT

Details and patient eligibility

About

this study is an individual patient level meta-analysis of randomized clinical trials, to evaluate the influence of ethnicity, to study whether the relative tradeoff between ischemia and bleeding is distinct by ethnicity.

Enrollment: 16,000 estimated patients

Sex: All

Ages: 19 to 100 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• patients enrolled in previous RCTs related to the duration of dural antiplatelet agent therapy